Chime Biologics is a leading global CDMO that enables its partners’ success in biologics. By leveraging our innovative R&D and manufacturing capabilities, we empower the entire biologics processes – from cell line development to commercial manufacturing – enabling customers to deliver affordable and accessible biologics that benefit patients worldwide.

With over 400 skilled employees, Chime Biologics leverages its comprehensive capabilities and internationally-recognized expertise to provide one-stop integrated solutions to worldwide customers. Relying on cell line development and advanced technology development from its Chime Biologics Innovation Center in Shanghai and proven success in IND-enabling through NDA/BLA filing at its Wuhan campus, Chime Biologics is providing high-quality pre-clinical, clinical and commercial manufacturing solutions.

Chime Biologics success is driven by reliable, compliant, flexible and fast-paced services from its innovative talent and operational excellence. We share a common goal to make cutting-edge biologics affordable and accessible to all patients globally, fulfilling its commitment to human health.

For more information, please visit: www.chimebiologics.com.